AGFB Stock Overview
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.18 |
| 52 Week High | €2.88 |
| 52 Week Low | €0.98 |
| Beta | 0.63 |
| 1 Month Change | -8.24% |
| 3 Month Change | -0.34% |
| 1 Year Change | -56.13% |
| 3 Year Change | -71.25% |
| 5 Year Change | -69.37% |
| Change since IPO | -94.50% |
Recent News & Updates
Recent updates
Agfa-Gevaert NV (EBR:AGFB) Held Back By Insufficient Growth Even After Shares Climb 27%
Mar 30
Does Agfa-Gevaert (EBR:AGFB) Have A Healthy Balance Sheet?
Apr 28A Look At The Intrinsic Value Of Agfa-Gevaert NV (EBR:AGFB)
Apr 19Agfa-Gevaert NV's (EBR:AGFB) About To Shift From Loss To Profit
Mar 13Here's What Agfa-Gevaert NV's (EBR:AGFB) Shareholder Ownership Structure Looks Like
Feb 04
A Look At Agfa-Gevaert's (EBR:AGFB) Share Price Returns
Dec 31Agfa-Gevaert (EBR:AGFB) Has A Somewhat Strained Balance Sheet
Nov 27Shareholder Returns
| AGFB | BE Healthcare Services | BE Market | |
|---|---|---|---|
| 7D | -0.2% | -2.5% | -0.06% |
| 1Y | -56.1% | -2.0% | -5.0% |
Return vs Industry: AGFB underperformed the Belgian Healthcare Services industry which returned -2% over the past year.
Return vs Market: AGFB underperformed the Belgian Market which returned -5% over the past year.
Price Volatility
| AGFB volatility | |
|---|---|
| AGFB Average Weekly Movement | 8.1% |
| Healthcare Services Industry Average Movement | 6.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in BE Market | 7.7% |
| 10% least volatile stocks in BE Market | 2.5% |
Stable Share Price: AGFB has not had significant price volatility in the past 3 months.
Volatility Over Time: AGFB's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1867 | 7,000 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
| AGFB fundamental statistics | |
|---|---|
| Market cap | €182.69m |
| Earnings (TTM) | -€53.00m |
| Revenue (TTM) | €1.15b |
0.2x
P/S Ratio-3.4x
P/E RatioIs AGFB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGFB income statement (TTM) | |
|---|---|
| Revenue | €1.15b |
| Cost of Revenue | €792.00m |
| Gross Profit | €358.00m |
| Other Expenses | €411.00m |
| Earnings | -€53.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | -0.34 |
| Gross Margin | 31.13% |
| Net Profit Margin | -4.61% |
| Debt/Equity Ratio | 3.5% |
How did AGFB perform over the long term?
See historical performance and comparison